Crescent Grove Advisors’s NetEase NTES Stock Holding History

Crescent Grove Advisors’s Portfolio NTES Stock Details NTES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,008	Closed	-$204K	–	305
2021 Q4	$204K	Sell	2,008 -492	-20%	-$50K	0.02%	281
2021 Q3	$214K	Hold	2,500	–	–	0.02%	248
2021 Q2	$288K	Sell	2,500 -1,445	-37%	-$159K	0.03%	201
2021 Q1	$407K	Hold	3,945	–	–	0.05%	140
2020 Q4	$378K	Hold	3,945	–	–	0.05%	132
2020 Q3	$359K	Sell	3,945 -555	-12%	-$52.2K	0.07%	123
2020 Q2	$386K	Hold	4,500	–	–	0.08%	102
2020 Q1	$289K	Hold	4,500	–	–	0.06%	103
2019 Q4	$276K	Hold	4,500	–	–	0.05%	133
2019 Q3	$240K	Hold	4,500	–	–	0.05%	138
2019 Q2	$230K	Sell	4,500 -500	-10%	-$26.5K	0.04%	139
2019 Q1	$241K	Hold	5,000	–	–	0.05%	129
2018 Q4	$235K	Hold	5,000	–	–	0.05%	139
2018 Q3	$228K	Hold	5,000	–	–	0.05%	124
2018 Q2	$253K	Hold	5,000	–	–	0.06%	117
2018 Q1	$280K	Hold	5,000	–	–	0.07%	110
2017 Q4	$345K	Hold	5,000	–	–	0.09%	91
2017 Q3	$264K	Hold	5,000	–	–	0.07%	111
2017 Q2	$301K	Buy	+5,000	New	+$287K	0.09%	98

Other funds holding NTES

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

GAMH

Greenwoods Asset Management (HK) Hong Kong $2.19B AUM 50.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Crescent Grove Advisors's NTES Position: Q1 2022 in Review

Crescent Grove Advisors sold out of NetEase (NTES) in Q1 2022, closing a stake of 2,008 shares — an estimated $204K sold.

Crescent Grove Advisors first reported a position in NTES in Q2 2017 and held it in 19 quarters. The position peaked at $407K in Q1 2021. 384 funds tracked by Wall St. Rank hold NTES as of Q1 2022.

Crescent Grove Advisors reported no remaining NetEase position as of Q1 2022 after selling out during the quarter.
Crescent Grove Advisors sold 2,008 NetEase shares in Q1 2022, an estimated $204K.
Crescent Grove Advisors first reported a position in NetEase in Q2 2017 and held it in 19 quarters.
Crescent Grove Advisors's NetEase position peaked at $407K in Q1 2021.
384 funds tracked by Wall St. Rank held NetEase as of Q1 2022.

Based on Crescent Grove Advisors's 13F filing for Q1 2022, filed 4 May 2022.